Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122929894 | 12292989 | 4 | F | 2014 | 20160808 | 20160421 | 20160815 | EXP | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-23798BP | BOEHRINGER INGELHEIM | 76.41 | YR | F | Y | 107.50000 | KG | 20160815 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122929894 | 12292989 | 1 | PS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | 300 MG | Y | 22512 | 150 | MG | CAPSULE | BID | |||||
| 122929894 | 12292989 | 2 | SS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | 300 MG | Y | 22512 | 150 | MG | CAPSULE | BID | |||||
| 122929894 | 12292989 | 3 | C | COENZYME Q10 | UBIDECARENONE | 1 | Oral | 100 MG | 0 | 100 | MG | CAPSULE | QD | ||||||
| 122929894 | 12292989 | 4 | C | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDELOSARTAN POTASSIUM | 1 | Oral | DOSE PER APPLICATION AND DAILY DOSE: 100 MG / 25 MG | 0 | TABLET | QD | ||||||||
| 122929894 | 12292989 | 5 | C | PRAVASTATIN SODIUM. | PRAVASTATIN SODIUM | 1 | Oral | 40 MG | 0 | 40 | MG | TABLET | QD | ||||||
| 122929894 | 12292989 | 6 | C | RYTHMOL | PROPAFENONE HYDROCHLORIDE | 1 | Oral | 3 ANZ | 0 | TABLET | TID | ||||||||
| 122929894 | 12292989 | 7 | C | Terazosin HCl | TERAZOSIN HYDROCHLORIDE | 1 | Oral | 2 MG | 0 | 2 | MG | CAPSULE | QD | ||||||
| 122929894 | 12292989 | 8 | C | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Oral | 3 ANZ | 0 | TABLET | TID | ||||||||
| 122929894 | 12292989 | 9 | C | LASIX | FUROSEMIDE | 1 | Oral | 40 MG | 0 | 40 | MG | TABLET | QD | ||||||
| 122929894 | 12292989 | 10 | C | VITAMIN C | ASCORBIC ACID | 1 | Oral | 500 MG | 0 | 500 | MG | CAPSULE | QD | ||||||
| 122929894 | 12292989 | 11 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 40 MG | 0 | 40 | MG | QD | |||||||
| 122929894 | 12292989 | 12 | C | CENTRUM SILVER | MINERALSVITAMINS | 1 | Oral | 0 | QD | ||||||||||
| 122929894 | 12292989 | 13 | C | IRON | IRON | 1 | Oral | DOSE PER APPLICATION AND DAILY DOSE: 325 MG (65 FE) | 0 | TABLET | QD | ||||||||
| 122929894 | 12292989 | 14 | C | FLEXERIL | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | Oral | 10 MG | 0 | 10 | MG | TABLET | QD | ||||||
| 122929894 | 12292989 | 15 | C | CALCIUM | CALCIUM | 1 | Oral | 500 MG | 0 | 500 | MG | TABLET | QD | ||||||
| 122929894 | 12292989 | 16 | C | CLONIDINE HCL | CLONIDINE HYDROCHLORIDE | 1 | Oral | 0.3 MG | 0 | .1 | MG | TABLET | TID | ||||||
| 122929894 | 12292989 | 17 | C | VENTOLIN | ALBUTEROL SULFATE | 1 | Respiratory (inhalation) | 1 ANZ | 0 | INHALATION SOLUTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122929894 | 12292989 | 1 | Atrial fibrillation |
| 122929894 | 12292989 | 3 | Product used for unknown indication |
| 122929894 | 12292989 | 4 | Hypertension |
| 122929894 | 12292989 | 5 | Blood cholesterol increased |
| 122929894 | 12292989 | 6 | Atrial fibrillation |
| 122929894 | 12292989 | 7 | Product used for unknown indication |
| 122929894 | 12292989 | 8 | Rheumatoid arthritis |
| 122929894 | 12292989 | 9 | Product used for unknown indication |
| 122929894 | 12292989 | 10 | Product used for unknown indication |
| 122929894 | 12292989 | 11 | Product used for unknown indication |
| 122929894 | 12292989 | 12 | Product used for unknown indication |
| 122929894 | 12292989 | 13 | Product used for unknown indication |
| 122929894 | 12292989 | 14 | Product used for unknown indication |
| 122929894 | 12292989 | 15 | Product used for unknown indication |
| 122929894 | 12292989 | 16 | Product used for unknown indication |
| 122929894 | 12292989 | 17 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122929894 | 12292989 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122929894 | 12292989 | Anaemia | Anaemia |
| 122929894 | 12292989 | Asthenia | |
| 122929894 | 12292989 | Chest pain | |
| 122929894 | 12292989 | Dyspnoea | |
| 122929894 | 12292989 | Faeces discoloured | |
| 122929894 | 12292989 | Fatigue | |
| 122929894 | 12292989 | Gastrointestinal haemorrhage | Gastrointestinal haemorrhage |
| 122929894 | 12292989 | Malaise |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122929894 | 12292989 | 1 | 20110523 | 20150106 | 0 | |
| 122929894 | 12292989 | 2 | 20150116 | 0 | ||
| 122929894 | 12292989 | 6 | 20141215 | 0 |